Newborn screening for congenital infectious diseases

Emerging Infectious Diseases

Volumn 10, Issue 6, 2004, Pages 1069-1073

  Neto, Eurico Camargo ^a,b,c   Rubin, Rosélia ^b   Schulte, Jaqueline ^b   Giugliani, Roberto ^a,c,d  

^a FEDERAL UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

^b Nobel RIE Laboratory   (Brazil)

^c Neonatal Screening Center   (Brazil)

^d HOSPITAL DE CLÍNICAS DE PORTO ALEGRE   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN G; IMMUNOGLOBULIN M;

ADULT; ANTIBODY DETECTION; ARTICLE; BLOOD SAMPLING; CHAGAS DISEASE; CONGENITAL DISORDER; CONGENITAL INFECTION; CONTROLLED STUDY; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTION; ENDEMIC DISEASE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; METABOLIC DISORDER; NEWBORN; NEWBORN SCREENING; RUBELLA; RUBELLA VIRUS; TOXOPLASMA GONDII; TOXOPLASMOSIS; TRYPANOSOMA CRUZI; ANIMAL; BLOOD; BRAZIL; CONGENITAL RUBELLA SYNDROME; CONGENITAL TOXOPLASMOSIS; CYTOMEGALIC INCLUSION BODY DISEASE; DISEASE TRANSMISSION;

ADULT; ANIMALS; BRAZIL; CHAGAS DISEASE; CYTOMEGALOVIRUS INFECTIONS; DISEASE TRANSMISSION, VERTICAL; FEMALE; HUMANS; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; INFANT, NEWBORN; RUBELLA SYNDROME, CONGENITAL; TOXOPLASMOSIS, CONGENITAL;

EID: 3543151282     PISSN: 10806040     EISSN: None     Source Type: Journal    
DOI: 10.3201/eid1006.030830     Document Type: Article

References (28)

1. Wallon M, Liou C, Garner P, Peyron F. Congenital toxoplasmosis: systematic review of evidence of efficacy of treatment in pregnancy. BMJ. 1999;318:1511-4.
2. Gras L, Gilbert R, Ades A, Dunn D. Effect of prenatal treatment on the risk of intracranial and ocular lesions in children with congenital toxoplasmosis. Int J Epidemiol. 2001;30:1309-13.
3. Lebech M, Andersen O, Christensen NC, Hertel J, Nielsen HE, Peitersen B, et al. Feasibility of neonatal screening for toxoplasma infection in the absence of prenatal treatment. Lancet. 1999;353:1834-7.
4. Eskild A, Oxman A, Magnus P, Bjorndal A, Bakketeig LS. Screening for toxoplasmosis in pregnancy: what is the evidence of reducing a health problem? J Med Screen. 1996;3:188-94.
5. Guerina NG, Hsu HW, Meissner HC, Maguire JH, Lynfield R, Stechenberg B, et al. Neonatal serologic screening and early treatment for congenital Toxoplasma gondii infection. The New England Regional Toxoplasma Working Group. N Engl J Med. 1994;330:1858-63.
6. Jones JL, Lopez A, Wilson M, Schulkin J, Gibbs R. Congenital toxoplasmosis: a review. Obstet Gynecol Surv. 2001;56:296-305.
7. Wanderley DM, Correa FM. Epidemiology of Chagas' heart disease. Rev Paul Med. 1995;113:742-9.
8. Mancebo R, Fernandez N, Calegari L. Seroprevalence of T. cruzi infection in 6 and 12 year-old school children from three Uruguayan endemic departments. Bol Chil Parasitol. 1999;54:51-6.
9. Jaramillo R, Bryan JP, Schur J, Pan AA. Prevalence of antibody to Trypanosoma cruzi in three populations in Belize. Am J Trop Med Hyg. 1997;57:298-301.
10. Azogue E. Women and congenital Chagas' disease in Santa Cruz, Bolivia: epidemiological and sociocultural aspects. Soc Sci Med. 1993;37:503-11.
11. Russomando G, de Tomassone MM, de Guillen I, Acosta N, Vera N, Almiron M, et al. Treatment of congenital Chagas' disease diagnosed and followed up by the polymerase chain reaction. Am J Trop Med Hyg. 1998;59:487-91.
12. Basombrio MA, Nasser J, Segura MA, Marco D, Sanchez Negrette O, Padilla M, et al. The transmission of Chagas' disease in Salta and the detection of congenital cases. Medicina (B Aires). 1999;59:143-6.
13. Contreras S, Fernandez MR, Aguero F, Desse J, Orduna T, Martino O. Congenital Chagas-Mazza disease in Salta, Argentine. Rev Soc Bras Med Trop. 1999;32:633-45.
14. Pays JF. Human American trypanosomiasis 90 years after its discovery by Carlos Chagas. II-Clinical aspects, physiopathology, diagnosis and treatment. Med Trop (Madr). 1999;59:79-94.
15. Trincado DE, Rawlinson WD. Congenital and perinatal infections with cytomegalovirus. J Paediatr Child Health. 2001;37:187-92.
16. Harris S, Ahlfors K, Ivarsson S, Lemmark B, Svanberg L. Congenital cytomegalovirus infection and sensorineural hearing loss. Ear Hear. 1984;5:352-5.
17. Damato EG, Winnen CW. Cytomegalovirus infection: perinatal implications. J Obstet Gynecol Neonatal Nurs. 2002;31:86-92.
18. Peckham C, Tookey P, Logan S, Giaquinto C. Screening options for prevention of congenital cytomegalovirus infection. J Med Screen. 2001;8:119-24.
19. Frey TK. Neurological aspects of rubella virus infection. Intervirology. 1997;40:167-75.
20. Cutts FT, Vynnycky E. Modelling the incidence of congenital rubella syndrome in developing countries. Int J Epidemiol. 1999;28:1176-84.
21. Neto EC, Anele E, Rubin R, Brites A, Schulte J, Becker D, et al. High prevalence of congenital toxoplasmosis in Brazil estimated from a three-years prospective neonatal screening. Int J Epidemiol. 2000;29:941-7.
22. Jaisson-Hot I, Wallon M, al Kurdi M, Thulliez P, Kahi S, Cozon G, et al. Congenital toxoplasmosis. Transitory negative serology. Presse Med. 2001;30:1001-4.
23. Ambroise-Thomas P, Schweitzer M, Pinon JM, Thiebaugeorges O. Prevention of congenital toxoplasmosis in France. Risk assessment. Results and perspectives of prenatal screening and newborn follow up. Bull Acad Natl Med. 2001;185:665-83.
24. Fowler KB, Dahle AJ, Boppana SB, Pass RF. Newborn hearing screening: will children with hearing loss caused by congenital cytomegalovirus infection be missed? J Pediatr. 1999;135:60-4.
25. Remington JS, McLeod R, Desmonts SG. Toxoplasmosis. In: Remington JS, Klein JO, editors. Infectious diseases of the fetus and newborn infant. Philadelphia: WB Saunders; 1995. p. 140-267.
26. Boppana SB, Rivera LB, Fowler KB, Mach M, Britt WJ. Intrauterine transmission of cytomegalovirus to infants of women with preconceptional immunity. N Engl J Med. 2001;344:1366-71.
27. Weng YH, Chu SM, Lien RI, Chou YH, Lin TY. Clinical experience with ganciclovir and anti-cytomegalovirus immunoglobulin treatment for a severe case of congenital cytomegalovirus infection. Chang Gung Med J. 2003;26:128-32.
28. Ushida M, Katow S, Furukawa S. Congenital rubella syndrome due to infection after maternal antibody conversion with vaccine. Jpn J Infect Dis. 2003;56:68-9.